New Zealand markets closed

ResMed Inc. (RMD)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
215.72+6.09 (+2.91%)
At close: 04:00PM EDT
215.72 0.00 (0.00%)
After hours: 04:30PM EDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2021
30/06/2020
30/06/2019
Total revenue
3,539,493
3,196,825
2,957,013
2,606,572
Cost of revenue
1,546,991
1,357,725
1,239,227
1,069,987
Gross profit
1,992,502
1,839,100
1,717,786
1,536,585
Operating expenses
Research development
249,133
225,284
201,946
180,651
Selling general and administrative
725,966
670,387
676,689
645,010
Total operating expenses
1,005,975
926,749
908,727
900,599
Operating income or loss
986,527
912,351
809,059
635,986
Interest expense
-
23,989
40,377
36,156
Total other income/expenses net
-2,866
-5,062
-36,615
-83,282
Income before tax
961,605
883,662
733,088
518,847
Income tax expense
182,129
409,157
111,414
114,255
Income from continuing operations
779,476
474,505
621,674
404,592
Net income
779,476
474,505
621,674
404,592
Net income available to common shareholders
779,476
474,505
621,674
404,592
Basic EPS
-
3.27
4.31
2.83
Diluted EPS
-
3.24
4.27
2.80
Basic average shares
-
145,313
144,338
143,111
Diluted average shares
-
146,451
145,652
144,484
EBITDA
-
1,099,169
954,838
705,798